Quarterly report pursuant to Section 13 or 15(d)

Equity Securities (Details Narrative)

v3.24.2.u1
Equity Securities (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
 1 Months Ended 6 Months Ended
Jun. 07, 2024
May 31, 2024
May 21, 2024
Nov. 30, 2023
Nov. 20, 2023
May 26, 2023
Mar. 31, 2023
Mar. 20, 2023
Jun. 30, 2024
Dec. 31, 2023
Warrants outstanding                 1,109,705 772,973
Warrant reduced description                 from $318.00 to $42.30 per share upon closing of the March 2023 Offering  
Preferred stock authorized                 10,000,000 10,000,000
Net cash proceeds from PIPE           $ 1.5        
Received net cash proceeds       $ 2.0            
Offering expenses       $ 3.0            
Underwriters discounts and offering expenses           $ 0.3        
Equity securities Abeyance                   182,000
Preferred stock par value                 $ 0.0001 $ 0.0001
Exercise price per share   $ 4.91   $ 9.7655 $ 42.30          
Reduced exercise price   $ 5.16   $ 5.16 9.7665          
Description of abeyance shares                 the Holder left 182,000 shares in abeyance at the Company’s transfer agent to be delivered to the Holder at their request, which were then delivered to the Holder on January 8, 2024  
Warrants Member                    
Warrants outstanding                 0  
Equity securities Abeyance                 0  
ATM Agreement                    
Provision for sale of common stock 1,157,761                  
Commission rate for sales agent 3.00%                  
Common stock par value $ 0.0001                  
May 2024 Inducement                    
Warrants to purchase shares of Common Stock   601,174 516,336              
Exchange Series A Common Warrants to Series B Common Warrants   431,498                
Equity securities Abeyance                 267,000  
Exercise price per share           $ 32.40        
Reduced exercise price   $ 5.16     $ 9.7665          
Net cash proceeds   $ 2.3                
Description of abeyance shares                 he Holders left 267,000 shares in abeyance at the Company’s transfer agent to be delivered to the Holders at their request  
Common Stock and Preferred Stock                    
Net cash proceeds               $ 4.2    
Underwriters' discounts and offering expenses               $ 0.8    
Common stock, shares sold           30,570   5,666    
Warrant [Member]                    
Warrants outstanding                 1,109,705  
Fair value, per share                 $ 2.39  
Warrants to purchase shares of Common Stock   516,336                
Warrants, expire date                 April 2022  
Net cash proceeds   $ 2.3     $ 2.0          
Equity issuance cost   $ 1.5     $ 0.3   $ 0.1      
Series A Common Stock Warrants [Member]                    
Warrants to purchase shares of Common Stock   601,174   247,196 247,196          
Exchange Series A Common Warrants to Series B Common Warrants   431,498   215,749 215,749          
Common and Pre-Funded Warrants [Member]                    
Warrant units to purchase stocks           53,391        
Warrants to purchase shares of Common Stock               107,874    
Pre-funded warrants to purchase shares of Common Stock               102,208    
Warrants sold to purchase one share of common stock           22,821        
Exercise price           $ 0.0001   $ 0.0001    
PIPE | Warrants Member                    
Warrants to purchase shares of Common Stock         231,473          
Warrant units to purchase stocks               107,874    
Exercise price               $ 42.30    
May 2023 | PIPE Common Warrants                    
Warrants outstanding                   53,391
Exercise price           32.40     $ 32.40  
Offering price           $ 34.275        
Warrant units to purchase stocks           53,391        
Warrants sold to purchase one share of common stock           53,391